KRAS and prostate cancer: For instance, Xu et al. demonstrated that miR-143 inhibits prostate cancer cell proliferation and migration, and it can also enhance the sensitivity of prostate cancer cells to the chemotherapy drug docetaxel by targeting key oncogenes like KRAS [24].